language_icon
EN
HI

Jagsonpal Pharmaceuticals Share price

JAGSNPHARM

210.37

0.00 (0.00%)
NSE
BSE
Last updated on 30 Apr, 2026 | 15:59 IST
Today's High

212.90

Today's Low

205.41

52 Week Low

155.00

52 Week High

301.65

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Jagsonpal Pharmaceuticals Chart

Jagsonpal Pharmaceuticals Share Key Metrics

Volume
2.90 L
Market Cap
1407.17 CR
LTQ@LTP
1@210.37
ATP
209.8
Var Margin
21.95 %
Circuit Range
167.07-250.59
Delivery %
60.61 %
Value
6.08 CR
ASM/GSM
No
Market Lot
1

Summary

Jagsonpal Pharmaceuticals share price stands at ₹210.37 at 30 Apr, 2026 | 15:59. The stock Jagsonpal Pharmaceuticals intraday movement has stayed between ₹205.41 and ₹212.90, while on a 52-week basis it has fluctuated from ₹155.00 to ₹301.65.
In terms of trading activity, Jagsonpal Pharmaceuticals has recorded a volume of 289912 shares. The Jagsonpal Pharmaceuticals has a market cap of ₹66890450. The stock’s Average Traded Price (ATP) stands at ₹20980, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1, 21037.
The Jagsonpal Pharmaceuticals operates within a circuit range of ₹167.07-250.59 – ₹167.07-250.59, with a Value of ₹6.08 CR. The Delivery Percentage for the day is 60.61%. Additionally, Jagsonpal Pharmaceuticals currently falls under the No framework, and trades with a market lot size of 1.

Jagsonpal Pharmaceuticals Fundamentals

View More
P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

65.48

Sector P/B

3.5

Sec. Div. Yield

0.57

Jagsonpal Pharmaceuticals Resistance and Support

Pivot 209.56

Resistance

First Resistance

213.71

Second Resistance

217.05

Third Resistance

221.2

Support

First Support

206.22

Second Support

202.07

Third Support

198.73

Jagsonpal Pharmaceuticals Shareholding Pattern

View More
  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

67.89%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

2.44%

Domestic Institutional Investors

0.22%

Retail

29.45%

Others

0%

Total Promoters
MAR '26
67.89%

Jagsonpal Pharmaceuticals Corporate Actions

DateAgenda
2026-04-27Audited Results & Final Dividend
2026-03-12Buy Back of Shares
2026-01-21Quarterly Results
2025-11-03Quarterly Results
2025-07-26Quarterly Results
2025-05-06Audited Results & Final Dividend
2025-01-22Quarterly Results

Jagsonpal Pharmaceuticals News

Jagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Jagsonpal Pharma announced a buyback offer of up to 1.6 million equity shares, representing 2.39% of its total equity, for Rs. 250 per share. The total buyback size is Rs. 40 crore, offering a premium of approximately 40% over recent market prices. The record date for determining eligible shareholders is May 4, 2026, and promoters will not participate.
Apr 29 2026 17:04:00

Jagsonpal Pharmaceuticals Ltd - 507789 - Corporate Action-Board approves Dividend

Jagsonpal Pharmaceuticals board recommended a ₹4 per equity share dividend for FY26. This 200% payout is subject to shareholder approval at the upcoming AGM.
Apr 27 2026 21:04:00

Jagsonpal Pharmaceuticals Ltd - 507789 - Intimation Of Record Date For The Purpose Of Buy-Back Of Up To 16,00,000 Fully Paid-Up Equity Shares Of Face Value ?2/- Each At A Price Of ?250/- Per Share, For An Aggregate Amount Not Exceeding ?40 Crores

Jagsonpal Pharmaceuticals announced May 04, 2026 as the record date for its buyback. The company plans to acquire up to 16 lakh equity shares at ₹250/share, totaling ₹40 crores.
Apr 27 2026 20:04:00

Jagsonpal Pharmaceuticals Ltd - 507789 - Corporate Action-Board to consider Dividend

Jagsonpal Pharmaceuticals board recommended a ₹4 per equity share dividend for FY26. This 200% payout is subject to shareholder approval at the upcoming AGM.
Apr 27 2026 19:04:00

Jagsonpal Pharmaceuticals Ltd - 507789 - Board Meeting Outcome for Outcome Of Board Meeting

Jagsonpal Pharmaceuticals reported FY26 revenue of ₹287.23 crore, up 6.88% YoY, and a net profit of ₹43.08 crore, down 22.2% YoY. The board also recommended a final dividend of ₹4 per equity share for the year ended March 31, 2026.
Apr 27 2026 19:04:00

Jagsonpal Pharmaceuticals Ltd - 507789 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

Jagsonpal Pharmaceuticals shareholders approved buyback of up to 16 lakh equity shares at ₹250 each, totalling ₹40 crores, through postal ballot. The resolution passed with 99.99% votes in favour.
Apr 27 2026 07:04:00

Jagsonpal Pharmaceuticals Ltd - 507789 - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

Jagsonpal Pharmaceuticals shareholders approved buyback of up to 16 lakh equity shares at ₹250 each, totalling ₹40 crores, through postal ballot. The resolution passed with 99.99% votes in favour.
Apr 27 2026 07:04:00

Jagsonpal Pharmaceuticals Ltd - 507789 - Board Meeting Intimation for Prior Intimation Of Board Meeting

Jagsonpal Pharmaceuticals board meeting is scheduled for April 27, 2026. The agenda includes considering and approving the Q4 FY26 audited financial results and a dividend recommendation for the financial year ending March 31, 2026.
Apr 20 2026 17:04:00
Read More

About Jagsonpal Pharmaceuticals

NSE : 4410  
BSE : 507789  
ISIN : INE048B01035  

Jagsonpal Pharmaceuticals Management

NamePosition
Pratham RawalCompany Secretary & Compliance Officer
Harsha RaghavanChairperson
View More

Jagsonpal Pharmaceuticals FAQs

The Buying Price of Jagsonpal Pharmaceuticals share is 210.37 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Jagsonpal Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Jagsonpal Pharmaceuticals, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Jagsonpal Pharmaceuticals shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Jagsonpal Pharmaceuticals shares is 0. Useful to assess the stock's value relative to its book value.

To assess Jagsonpal Pharmaceuticals’s valuation compare Sector P/E, P/B which are 65.48 & 3.5 with sector averages, along with growth rates and financial metrics.

The Market Cap of Jagsonpal Pharmaceuticals is 1407.17 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Jagsonpal Pharmaceuticals share price is 301.65 & 155.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Jagsonpal Pharmaceuticals belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost